Announcements and Circulars Corporate Governance Investor Inquiry

30

2025.12

LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

30

2025.12

ANNOUNCEMENT - (1) COMPLETION OF VERY SUBSTANTIAL ACQUISITION AND CONNECTED TRANSACTION INVOLVING ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE; (2) REVERSE TAKEOVER; (3) THE ONE-OFF SHARE OPTION PLAN; (4) CHANGE OF COMPANY NAME; (5) REMOVAL OF STOCK MARKER; (6) CHANGE IN THE COMPOSITION OF THE BOARD; (7) CHANGE OF AUTHORISED REPRESENTATIVES AND AGENT FOR THE SERVICES OF PROCESS IN HONG KONG; (8) CHANGE OF JOINT COMPANY SECRETARIES AND (9)CHANGE OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG

22

2025.12

DIS-APPLICATION OF RULES 18A.09 TO 18A.11 OF THE LISTING RULES

22

2025.12

ANNOUNCEMENT ON (1) POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 22 DECEMBER 2025; (2) GRANT OF WHITEWASH WAIVER AND CONSENT TO SPECIAL DEAL; AND (3) INCREASE IN AUTHORISED SHARE CAPITAL OF THE COMPANY

08

2025.12

VOLUNTARY ANNOUNCEMENT - THE INCLUSION OF LEROCICLIB (GB491) IN CHINA'S NATIONAL REIMBURSEMENT DRUG LIST

04

2025.12

(1) VERY SUBSTANTIAL ACQUISITION AND CONNECTED TRANSACTION INVOLVING ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE; (2) REVERSE TAKEOVER INVOLVING THE NEW LISTING APPLICATION; (3) APPLICATION FOR WHITEWASH WAIVER; (4) SPECIAL DEAL; (5) PROPOSED CHANGE OF COMPANY NAME; (6) PROPOSED INCREASE IN AUTHORISED SHARE CAPITAL OF THE COMPANY; AND (7) PROPOSED ADOPTION OF THE ONE-OFF SHARE OPTION PLAN; AND DESPATCH OF CIRCULAR

04

2025.12

CLOSURE OF REGISTER OF MEMBERS

04

2025.12

DOCUMENTS ON DISPLAY

04

2025.12

FORM OF PROXY FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD AT ROOM 501-02, 5/F, BUILDING 6, 690 BIBO ROAD, PUDONG NEW DISTRICT, SHANGHAI, CHINA ON MONDAY, 22 DECEMBER 2025 AT 10:00 A.M.

04

2025.12

NOTICE OF EXTRAORDINARY GENERAL MEETING

04

2025.12

(1) VERY SUBSTANTIAL ACQUISITION AND CONNECTED TRANSACTION INVOLVING ISSUE OF CONSIDERATION SHARES UNDER SPECIFIC MANDATE; (2) REVERSE TAKEOVER INVOLVING THE NEW LISTING APPLICATION; (3) APPLICATION FOR WHITEWASH WAIVER; (4) SPECIAL DEAL IN RELATION TO THE RETENTION PLAN OF THE SHAREHOLDER PERSONNEL; (5) PROPOSED CHANGE OF COMPANY NAME; (6) PROPOSED INCREASE IN AUTHORISED SHARE CAPITAL OF THE COMPANY; (7) PROPOSED ADOPTION OF THE ONE-OFF SHARE OPTION PLAN; AND (8) NOTICE OF EGM

Investor Inquiry

Edding Genor Group Holdings Limited

Room 406, Building 1, No. 36 Doukou Road, Hengqin, Zhuhai,China

Room 406, Building 1, No. 36 Doukou Road, Hengqin, Zhuhai,China

IR@eddingpharm.com

IR@eddingpharm.com